BlackRock Health Sciences Term Trust (NYSE:BMEZ) Stock Holdings Lifted by Brown Lisle Cummings Inc.

Brown Lisle Cummings Inc. raised its position in shares of BlackRock Health Sciences Term Trust (NYSE:BMEZ) by 17.0% in the fourth quarter, Holdings Channel reports. The firm owned 42,711 shares of the company’s stock after buying an additional 6,198 shares during the period. Brown Lisle Cummings Inc.’s holdings in BlackRock Health Sciences Term Trust were worth $615,000 as of its most recent SEC filing.

Several other institutional investors have also made changes to their positions in BMEZ. Brown Brothers Harriman & Co. bought a new position in BlackRock Health Sciences Term Trust during the third quarter valued at approximately $32,000. K2 Principal Fund L.P. acquired a new position in shares of BlackRock Health Sciences Term Trust during the 3rd quarter worth $158,000. Jane Street Group LLC bought a new position in shares of BlackRock Health Sciences Term Trust during the 3rd quarter valued at $357,000. Dakota Wealth Management lifted its stake in shares of BlackRock Health Sciences Term Trust by 23.4% in the 3rd quarter. Dakota Wealth Management now owns 22,509 shares of the company’s stock valued at $357,000 after purchasing an additional 4,267 shares during the last quarter. Finally, Kingswood Wealth Advisors LLC bought a new stake in BlackRock Health Sciences Term Trust in the fourth quarter worth $420,000.

BlackRock Health Sciences Term Trust Price Performance

BlackRock Health Sciences Term Trust stock opened at $16.38 on Tuesday. BlackRock Health Sciences Term Trust has a one year low of $14.27 and a one year high of $16.75. The company’s fifty day moving average price is $15.44 and its two-hundred day moving average price is $15.64.

BlackRock Health Sciences Term Trust Announces Dividend

The business also recently disclosed a monthly dividend, which was paid on Friday, January 31st. Stockholders of record on Wednesday, January 15th were issued a dividend of $0.1782 per share. This represents a $2.14 dividend on an annualized basis and a dividend yield of 13.05%. The ex-dividend date was Wednesday, January 15th.

About BlackRock Health Sciences Term Trust

BlackRock Health Sciences Trust II’s (BMEZ) (the ‘Trust’) investment objective is to provide total return and income through a combination of current income, current gains and long-term capital appreciation. The Trust seeks to achieve its investment objective by investing, under normal market conditions, at least 80% of its total assets in equity securities of companies principally engaged in the health sciences group of industries and equity derivatives with exposure to the health sciences group of industries.